Chiara Corti Selected Research

Chiara Corti Research Topics

Disease

31	Neoplasms (Cancer) 12/2023 - 12/2017
14	Breast Neoplasms (Breast Cancer) 12/2023 - 10/2018
3	Thymoma (Thymic Carcinoma) 01/2023 - 01/2022
3	COVID-19 01/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2023 - 02/2022
2	Melanoma (Melanoma, Malignant) 01/2022 - 09/2021
2	Carcinoma (Carcinomatosis) 01/2022 - 10/2018
2	Turcot syndrome 02/2020 - 10/2018
2	Microsatellite Instability 02/2020 - 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023
1	Carcinogenesis 06/2023
1	Nausea 01/2023
1	Vomiting 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 10/2022
1	Disease Progression 10/2022
1	Central Nervous System Diseases (CNS Diseases) 02/2022
1	Myasthenia Gravis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2021

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2018
5	Estrogen ReceptorsIBA 12/2023 - 10/2018
5	Immunoconjugates (Immunoconjugate)IBA 06/2023 - 06/2021
5	Hormones (Hormone)IBA 06/2023 - 11/2020
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2018
4	Proteins (Proteins, Gene)FDA Link 02/2023 - 10/2018
4	AntigensIBA 01/2022 - 06/2021
3	Phenobarbital (Luminal)FDA Link 12/2023 - 09/2018
3	human ERBB2 proteinIBA 11/2023 - 12/2017
3	PlatinumIBA 01/2023 - 10/2022
3	COVID-19 VaccinesIBA 01/2022 - 01/2021
3	VaccinesIBA 01/2022 - 01/2021
2	trastuzumab deruxtecanIBA 01/2023 - 01/2022
2	pembrolizumabIBA 09/2021 - 07/2019
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2020 - 01/2020
2	TensinsIBA 02/2020 - 01/2020
1	Glycoproteins (Glycoprotein)IBA 11/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2023
1	Adenosine Monophosphate (AMP)IBA 09/2023
1	TESIBA 09/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2023
1	LigandsIBA 06/2023
1	Ifosfamide FDA LinkGeneric 01/2023
1	AntibodiesIBA 01/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	CrizotinibIBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	avelumabIBA 10/2022
1	Axitinib (AG 013736)IBA 10/2022
1	Sunitinib (Sutent)FDA Link 10/2022
1	Interleukin Receptors (Interleukin Receptor)IBA 06/2022
1	Chemokine ReceptorsIBA 06/2022
1	Complement System Proteins (Complement)IBA 02/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	avapritinibIBA 01/2022
1	mRNA VaccinesIBA 11/2021
1	IpilimumabIBA 09/2021
1	VemurafenibIBA 09/2021
1	NivolumabIBA 09/2021
1	atezolizumabIBA 09/2021
1	cobimetinibIBA 09/2021
1	Monoclonal AntibodiesIBA 08/2021
1	blinatumomabIBA 08/2021
1	Bispecific AntibodiesIBA 08/2021
1	Cytotoxins (Cytolysins)IBA 06/2021
1	sacituzumab govitecanIBA 06/2021
1	Tamoxifen FDA LinkGeneric 11/2020

Therapy/Procedure

10	Therapeutics 06/2023 - 12/2017
8	Drug Therapy (Chemotherapy) 06/2023 - 10/2018
7	Immunotherapy 08/2023 - 02/2020
2	Precision Medicine 01/2023 - 01/2020
1	Continuity of Patient Care 01/2023
1	Chemoprevention 12/2021